Charlotte's Web Holdings (CWBHF) Other Non-Current Assets (2020 - 2026)
Charlotte's Web Holdings' (CWBHF) quarterly Other Non-Current Assets came in at $8000.0 in Q1 2026, down 98.28% year-on-year from $466000.0 in Q1 2025, and down 57.89% on a QoQ basis from $19000.0 in Q4 2025.
Charlotte's Web Holdings (CWBHF) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has 7 years of Other Non-Current Assets data on file, last reported at $8000.0 in Q1 2026.
- On a quarterly basis, Other Non-Current Assets fell 98.28% year-over-year to $8000.0 in Q1 2026; TTM through Mar 2026 was $8000.0, a 98.28% decrease from a year earlier, with the FY2025 full-year figure at $19000.0, down 73.24% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $8000.0, down from $19000.0 in the prior quarter.
- Over the last five years, Other Non-Current Assets for CWBHF reached as high as $6.0 million in Q3 2022 and fell as low as $8000.0 in Q1 2026.
- Historically, Other Non-Current Assets has averaged $1.4 million across 5 years, with a median of $703000.0 in 2023.
- Across the five-year window, Other Non-Current Assets jumped 179.83% in 2022 and tumbled 98.28% in 2026, its largest moves.
- Year by year, Other Non-Current Assets stood at $5.8 million in 2022, then sank by 87.82% to $703000.0 in 2023, then tumbled by 89.9% to $71000.0 in 2024, then tumbled by 73.24% to $19000.0 in 2025, then plunged by 57.89% to $8000.0 in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $8000.0 in Q1 2026, $19000.0 in Q4 2025, and $1.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 49.22 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.79 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 351.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 491.06 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 233.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.11 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 73.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 295.00 Mn |
| 10 | Charlotte's Web Holdings | 41.51 Mn | 36.32 Mn | 5.20 Mn | 8,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,000.00 |
| Dec 31, 2025 | 19,000.00 |
| Sep 30, 2025 | 1.02 Mn |
| Jun 30, 2025 | 416,000.00 |
| Mar 31, 2025 | 466,000.00 |
| Dec 31, 2024 | 71,000.00 |
| Sep 30, 2024 | 648,000.00 |
| Jun 30, 2024 | 534,000.00 |
| Mar 31, 2024 | 616,000.00 |
| Dec 31, 2023 | 703,000.00 |
| Sep 30, 2023 | 1.39 Mn |
| Jun 30, 2023 | 1.52 Mn |
| Mar 31, 2023 | 1.53 Mn |
| Dec 31, 2022 | 5.77 Mn |
| Sep 30, 2022 | 6.02 Mn |
| Jun 30, 2022 | 1.90 Mn |
| Mar 31, 2022 | 1.97 Mn |
| Dec 31, 2021 | 2.06 Mn |
| Dec 31, 2020 | 5.18 Mn |